Acne Treatment Market Size, Share, Growth Analysis, By Type(Retinoids, Antibiotics, Isotretinoin, Others), By Route of Administration(Oral, Topical), By Age Group(10 to 17, 18 to 44, 45 to 64, 65 Above), By Distribution Channel(Hospital Pharmacies, Retail & Online Pharmacies), By Region - Industry Forecast 2024-2031

Acne Treatment Market Driver

Acne's Global Increase Will Drive Market Growth

• Skin disorders are becoming more common all around the world. As a result, the number of patients choosing the treatment is fast expanding in North America, Europe, and the Asia Pacific. The advent of numerous acne therapy medications, such as retinoids, isotretinoin, and antibiotics in oral and topical forms is raising global knowledge of acne products and available treatment alternatives. As a result, rising patient awareness is expected to drive market expansion.
• Reduced costs for acne treatments and rising demand for hormonal therapy are two key factors propelling the market's revenue growth. The majority of topical treatments are ineffective on the cystic lumps that hormonal acne typically presents as. Users of oral medications may experience hormone balancing and internal skin clearing. Similar to this, anti-androgen medications work by reducing men's levels of androgen. Additionally, both men and women naturally produce this hormone in large amounts. However, an excess of androgen can worsen acne by interacting with the hair follicles that control the production of skin cells and oil. Hormonal therapies can be used to treat therapy-resistant acne in patients without hyperandrogenism as well as those who have cutaneous or biochemical signs of hyperandrogenism. It is anticipated that this will cause the demand for hormonal therapy to rise quickly.

Acne Treatment Market Restraint 

Adoption is being hampered by side effects associated with currently available drugs

• Despite the global prevalence of chronic acne, some constraints impede the growth of the acne treatment industry. According to the National Center for Biotechnology Information (NCBI), the most common adverse effects of antibiotics are nausea, vomiting, or diarrhoea, which occur in around 7% of tetracycline patients and 4% of macrolide patients. The Food and Drug Administration (FDA) of the United States has issued a warning against the use of some over-the-counter (OTC) drugs that might induce potentially fatal allergic reactions or extreme irritation.
• The skin positivity movement and a lack of knowledge about skin conditions, however, are limiting market revenue growth. The skin positivity movement concentrates on altering perceptions of skin and emphasizes on external appearance. The idea of embracing and loving one's skin, flaws and all is promoted by skin positivity. 
• Skin disorders are becoming more common all around the world. As a result, the number of patients choosing the treatment is fast expanding in North America, Europe, and the Asia Pacific. The advent of numerous acne therapy medications, such as retinoids, isotretinoin, and antibiotics in oral and topical forms is raising global knowledge of acne products and available treatment alternatives. As a result, rising patient awareness is expected to drive market expansion.
• Reduced costs for acne treatments and rising demand for hormonal therapy are two key factors propelling the market's revenue growth. The majority of topical treatments are ineffective on the cystic lumps that hormonal acne typically presents as. Users of oral medications may experience hormone balancing and internal skin clearing. Similar to this, anti-androgen medications work by reducing men's levels of androgen. Additionally, both men and women naturally produce this hormone in large amounts. However, an excess of androgen can worsen acne by interacting with the hair follicles that control the production of skin cells and oil. Hormonal therapies can be used to treat therapy-resistant acne in patients without hyperandrogenism as well as those who have cutaneous or biochemical signs of hyperandrogenism. It is anticipated that this will cause the demand for hormonal therapy to rise quickly.